NCI Explores AI to Screen For and Treat Pancreatic Cancer
The institute sees the emerging technology supporting treatment for patients by better controlling tumor growth.
A new initiative at the National Cancer Institute aims to create capabilities for detecting pancreatic cancer early and improving treatments for patients with mutations.
A big challenge with pancreatic cancer resides in the KRAS gene. When mutated, the gene can cause normal cells to become cancerous. A new therapy involving KRAS inhibitors and genetic testing can help patients screen for this earlier.
Dr. Christine Alewine, the NIH Lasker Scholar in the Laboratory of Molecular Biology at NCI’s Center for Cancer Research, discussed this breakthrough, how new advancements can serve as an alternative treatment for chemotherapy and where AI can make an impact. Plus, she notes how other health issues such as diabetes also plays a role in screening for pancreatic cancer.
-
Dr. Christine Alewine NIH Lasker Scholar in the Laboratory of Molecular Biology, Center for Cancer Research NCI
-
Securing AI Amid Rising Risks
NIST and Maximus explore how AI is transforming threat detection, identity protection and edge security and discuss how agencies can keep pace with the rapid tech changes.
20m watch -
CIOs Leverage Cloud to Unify Behavioral Health Services
CIOs shared how standardized infrastructure and real-time data capabilities are improving patient tracking, reporting and operational efficiency.
3m read -
Federal Modernization Hinges on Trusted Data, Simplified Procurement
Agency leaders are rethinking modernization strategies to meet the demands of data-driven missions and increasingly sophisticated cyber threats.
18m watch -
AI-Driven Modernization is Boosting Patient Satisfaction
UK public health leader says that AI and cloud tools can reshape patient interactions and back-office operations.
3m read
